{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-007224","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.980370+00:00","generated_at":"2026-05-16T21:15:06.020873+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Profound Medical signs exclusive distribution deal for TULSA-PRO in Australia, New Zealand","bullets":["Exclusive distribution & supply agreement with Getz Healthcare for TULSA-PRO system in Australia and New Zealand.","TULSA-PRO is an AI-powered, MRI-guided robotic system for real-time prostate ablation without surgery or radiation.","Partnership leverages Getz Healthcare's established distribution network in the region.","Profound also deploys direct sales in North America while partnering with strategic distributors internationally."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-007224","json":"https://secwatch.observer/filing/0001171843-25-007224.json","markdown":"https://secwatch.observer/filing/0001171843-25-007224.md","text":"https://secwatch.observer/filing/0001171843-25-007224.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325007224/0001171843-25-007224-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325007224/f8k_111225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:15:06.020873+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}